invoX Belgium SA
45.5 FTEinvoX Belgium reported total assets of €29.2m at the end of the 2025 financial year (annual accounts filed with the NBB on 23 Jul 2026), with 45.5 full-time equivalents.
By total assets for 2025, invoX Belgium ranks among the 50 largest of the 173 companies in its sector (NACE 2120) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of invoX Belgium shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets +380 % Headcount (avg FTE) +261 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
invoX Belgium's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 23 Jul 2026
- Year ended 31 Dec 2024filed on 18 Jul 2025
- Year ended 31 Dec 2023filed on 23 Jul 2024
- Year ended 31 Dec 2022filed on 19 Jul 2023
- Year ended 31 Dec 2021filed on 01 Jul 2022
invoX Belgium's financial analysis
- Solvency-220.8%sector median: 50.3%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of invoX Belgium
invoX Belgium's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0654.798.401
- VAT number
- BE0654798401
- Peppol
- Registered · 0208:0654798401 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 27 Apr 2016
- Registered office
- 3590 Diepenbeek
- Size
- Small · 45.5 FTE
- Latest accounts
- 2025 · filed on 23 Jul 2026
- Activity
- Manufacture of medicaments (NACE 21201)
invoX Belgium (SA) has been based in Diepenbeek since 2016, active in: manufacture of medicaments. For 2025, it reports a net loss of €21.0m and equity of −€64.6m; its revenue is not published. With 45.5 full-time equivalents, it is a small enterprise by headcount. Its solvency stands at -220.8%, below the median of its sector (50.3%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to invoX Belgium
Companies in the same business, of comparable size and area, outside its group.
- KiOmed Pharma Research and experimental development on natural sciences and engineering Herstal · balance sheet €19.7m
- Biocartis Research and experimental development on natural sciences and engineering Mechelen · balance sheet €61.8m
- Istar Medical Manufacture of medical and dental instruments and supplies Wavre · balance sheet €15.6m
- Sunrise Manufacture of irradiation, electromedical and electrotherapeutic equipment Namur · balance sheet €43.9m
- Boston Scientific Benelux Activities of agents involved in the wholesale of other particular products Machelen (Brab.) · balance sheet €34.0m
- Opella Healthcare Belgium NV/SA Manufacture of pharmaceutical preparations Machelen (Brab.) · balance sheet €32.3m
- Besins Healthcare Pharmtech Manufacture of pharmaceutical preparations Seraing · balance sheet €23.7m
- Fresenius Medical Care Belgium Wholesale of pharmaceutical and medical goods Willebroek · balance sheet €21.9m
Frequently asked questions about invoX Belgium
What is the revenue of invoX Belgium?
invoX Belgium files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of invoX Belgium?
In Belgium, the VAT number is the company number prefixed with BE: BE0654798401 for invoX Belgium, if the company is VAT-registered. Its company number (CBE) is 0654.798.401.
Where is the registered office of invoX Belgium?
According to the CBE register, the registered office of invoX Belgium is in 3590 Diepenbeek.
What is the equity of invoX Belgium?
At the close of the 2025 financial year, the equity of invoX Belgium amounts to -64,571,210 €, a solvency of -220.8% of total assets.
How many people work at invoX Belgium?
45.5 full-time equivalents on average according to the 2025 social balance sheet.
Who manages invoX Belgium?
The register lists 2 active mandates at invoX Belgium. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is invoX Belgium within its sector?
By total assets for 2025, invoX Belgium ranks among the 50 largest of the 173 companies in its sector (NACE 2120) in Belgium that filed accounts for that financial year.
The full file of invoX Belgium
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →